Guideline proposal 2026-NI-00136-J
The draft with the ID 2026-NI-00136-J is now in parallel review: the National Delegates and the responsible Committee are reviewing it at the same time.
Please provide your feedback by 27-08-2026 - otherwise it is assumed that you approve the draft. The guideline only advances once both groups have finished.
Guideline entry base data:
| Guideline ID: | 2026-NI-00136-J |
| Working title: | SNMMI/EANM Consensus statement on GLP-1 medications and their potential effects on nuclear medicine procedures, particularly FDG. |
Process overview
GPC/Office Formal Check
Writing in process
Under GPC review
Under committee/ND review
Under GPC final approval
Board final approval
Published
Best regards
Your EANM Team
Guideline Manager